Methods of using sustained release aminopyridine compositions
Details for Australian Patent Application No. 2005232732 (hide)
International Classifications
Event Publications
25 January 2007 Section 223 Application Allowed
Acorda Therapeutics, Inc. The time in which to enter the National Phase has been extended to 09 Dec 2006. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden ACT 2606 2006
1 February 2007 PCT application entered the National Phase
PCT publication WO2005/099701 Priority application(s): WO2005/099701
12 May 2011 Application Accepted
Published as AU-B-2005232732
8 September 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005232745-Polycyclic pyrimidines as potassium ion channel modulators
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser